Search Results 331-340 of 1067 for consists

  1. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

    Provides a new or recently obtained core needle biopsy, consisting of multiple cores, taken from the primary breast tumor(s) for central determination of HR ...

  2. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

    Scarring in the bile ducts blocks the flow of bile from the liver and damages liver tissue. A liver transplant is the only known cure.

  3. Dr. Jeremy Cutsforth-Gregory Archives - Mayo Clinic News Network

  4. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Peripheral blood B-cell count of > 5 x 10^9/L consisting of small to moderate size lymphocytes; Immunophenotyping consistent with CLL defined as. The ...

  5. A Study of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer - Mayo Clinic

    Males and their female partners who are of childbearing potential. Must be using highly effective contraception consisting of 2 forms of birth control (1 of ...

  6. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

    Scarring in the bile ducts blocks the flow of bile from the liver and damages liver tissue. A liver transplant is the only known cure.

  7. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

    Scarring in the bile ducts blocks the flow of bile from the liver and damages liver tissue. A liver transplant is the only known cure.

  8. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    ... consisting of a dose equivalent to prednisone (or equivalent) ≥ 40 mg/day orally for at least 3 weeks or intravenously for 1 week; OR; Inability to taper ...

  10. Mayo Clinic Year End 2022 Consolidated

    Deferred revenue: Deferred revenue consists of payments received in advance for grant, subscription, and tuition revenue. ... The Clinic's endowment funds consist ...